INBS vs. ICCM, GUTS, APT, ZYXI, EDAP, SURG, PSTV, MLSS, NEPH, and WOK
Should you be buying Intelligent Bio Solutions stock or one of its competitors? The main competitors of Intelligent Bio Solutions include IceCure Medical (ICCM), Fractyl Health (GUTS), Alpha Pro Tech (APT), Zynex (ZYXI), EDAP TMS (EDAP), SurgePays (SURG), Plus Therapeutics (PSTV), Milestone Scientific (MLSS), Nephros (NEPH), and WORK Medical Technology Group (WOK). These companies are all part of the "medical equipment" industry.
Intelligent Bio Solutions vs. Its Competitors
Intelligent Bio Solutions (NASDAQ:INBS) and IceCure Medical (NASDAQ:ICCM) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their profitability, analyst recommendations, risk, media sentiment, institutional ownership, dividends, valuation and earnings.
Intelligent Bio Solutions has higher earnings, but lower revenue than IceCure Medical. IceCure Medical is trading at a lower price-to-earnings ratio than Intelligent Bio Solutions, indicating that it is currently the more affordable of the two stocks.
Intelligent Bio Solutions has a beta of 4.59, meaning that its share price is 359% more volatile than the S&P 500. Comparatively, IceCure Medical has a beta of 0.32, meaning that its share price is 68% less volatile than the S&P 500.
33.0% of Intelligent Bio Solutions shares are held by institutional investors. Comparatively, 0.6% of IceCure Medical shares are held by institutional investors. 1.5% of Intelligent Bio Solutions shares are held by company insiders. Comparatively, 2.4% of IceCure Medical shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.
IceCure Medical has a consensus price target of $2.39, indicating a potential upside of 100.42%. Given IceCure Medical's stronger consensus rating and higher probable upside, analysts clearly believe IceCure Medical is more favorable than Intelligent Bio Solutions.
In the previous week, Intelligent Bio Solutions had 1 more articles in the media than IceCure Medical. MarketBeat recorded 2 mentions for Intelligent Bio Solutions and 1 mentions for IceCure Medical. Intelligent Bio Solutions' average media sentiment score of 1.40 beat IceCure Medical's score of 0.44 indicating that Intelligent Bio Solutions is being referred to more favorably in the media.
IceCure Medical has a net margin of -317.62% compared to Intelligent Bio Solutions' net margin of -346.22%. IceCure Medical's return on equity of -136.96% beat Intelligent Bio Solutions' return on equity.
Summary
IceCure Medical beats Intelligent Bio Solutions on 11 of the 17 factors compared between the two stocks.
Get Intelligent Bio Solutions News Delivered to You Automatically
Sign up to receive the latest news and ratings for INBS and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding INBS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Intelligent Bio Solutions Competitors List
Related Companies and Tools
This page (NASDAQ:INBS) was last updated on 8/28/2025 by MarketBeat.com Staff
MarketBeat All Access